Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Amicus Therapeutics (FOLD)

   0 (0%) 12-31 19:00
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 13.932 - 14.001 14.001 - 14.057
Low: 13.281 - 13.374 13.374 - 13.449
Close: 13.668 - 13.811 13.811 - 13.926

Technical analysis

as of: 2020-09-25 4:30:14 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 16.49     One year: 17.46
Support: Support1: 12.78    Support2: 10.63
Resistance: Resistance1: 14.12    Resistance2: 14.95
Pivot: 13.71
Moving Average: MA(5): 13.64     MA(20): 13.84
MA(100): 13.93     MA(250): 11.33
MACD: MACD(12,26): -0.19     Signal(9): -0.21
Stochastic oscillator: %K(14,3): 46.15     %D(3): 43.39
RSI: RSI(14): 47.92
52-week: High: 16.13  Low: 6.25  Change(%): 72.0
Average Vol(K): 3-Month: 196397  10-Days: 204192

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
FOLD has closed below upper band by 44.2%. Bollinger Bands are 29% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 25 Sep 2020
Here is why Amicus Therapeutics Inc. (FOLD) recent weekly performance of -0.86% shouldn’t bother you at All - The InvestChronicle

Wed, 23 Sep 2020
Amicus Therapeutics Inc. (NASDAQ:FOLD) is Waving the Bull Flag - The Oracle Dispatch

Tue, 22 Sep 2020
Health Check: How Prudently Does Amicus Therapeutics (NASDAQ:FOLD) Use Debt? - Simply Wall St

Mon, 21 Sep 2020
Wall Street Pummels FOLD After Recent Earnings Report -

Tue, 15 Sep 2020
Is Amicus Therapeutics, Inc. (FOLD) Going to Burn These Hedge Funds? - Yahoo Finance

Fri, 11 Sep 2020
Amicus Therapeutics Inc. (NASDAQ:FOLD) on the Path to Ruin - The Oracle Dispatch

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Shares Out. (M) 259
Shares Float (M) 206
% Held by Insiders 1.10
% Held by Institutions 109.87
Shares Short (K) 30,490
Shares Short P. Month (K) 31,070

Stock Financials

EPS -1.140
EPS Est This Year -1.320
EPS Est Next Year -1.020
Book Value (p.s.) 1.400
Profit Margin -129.10
Operating Margin -120.14
Return on Assets (ttm) -21.0
Return on Equity (ttm) -61.0
Qtrly Rev. Growth 41.3
Gross Profit (p.s.) 0.619
Sales Per Share 0.877
EBITDA (p.s.) -1.008
Qtrly Earnings Growth
Operating Cash Flow (M) -255
Levered Free Cash Flow (M) -143

Stock Valuations

PE Ratio -12.10
PEG Ratio
Price to Book value 9.85
Price to Sales 15.73
Price to Cash Flow -14.01

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.